Dr. umarani mosalikanti
APID: 10813
cap at IMU University Kaula Lumpur, Kaula Lumpur
 

Expertise


Pharmaceutical Sciences

Area of Interest


Medicinal chemistry, natural products, Pharmaceutical technology, Anti microbial resistance

Short Biography


User has not updated his/her Biography.

Honors and Awards


User has not updated his/her Awards & Honors.

Career Timeline


User has not updated his/her Career Timeline.

Publications


User has not updated his/her Publications.

Projects


Project: Design, synthesis, and evaluation of diaryl/heteroaryl pyrrole mannich bases as potential antidepressant agents.
Goal:
Current Stage: Completed
Starting Date:
Sponsored by: Department of Science and Technology, India
Projects
Project: Investigating Synthetic Pathways to Enhance 6-Shogaol’s Therapeutic Potential for Alzheimer’s Disease Treatment.
Goal:
Current Stage: Ongoing
Starting Date: 01/08/2024
Sponsored by: IMU University
Projects
Project: Synthesis and Evaluation of Silver Nanoparticles from Teucrium polium Aerial Parts for Anticancer Activity in Colon Cancer Cells.
Goal: Completed
Current Stage:
Starting Date: 10/04/2024
Sponsored by: IMU University
Projects
Project: Identification of new drug-like molecules as NRF2 activators using machine learning and in silico studies.
Goal:
Current Stage: Ongoing
Starting Date: 01/03/2025
Sponsored by: IMU University
Projects
Project: Investigation of the anticancer potential of glucomoringin against colon cancer cells.
Goal:
Current Stage: Ongoing
Starting Date: 10/03/2025
Sponsored by: IMU University
Projects
Project: In Silico Studies on Drug Repurposing and Virtual Screening Across All Serotypes of the Dengue Virus.
Goal:
Current Stage: Completed
Starting Date: 01/04/2025
Sponsored by: IMU University
Projects
Project: A novel approach to circumvent the drug resistance in Mycobacterium tuberculosis by simultaneously inhibiting InhA and DprE1.
Goal:
Current Stage: Ongoing
Starting Date: 01/07/2024
Sponsored by: IMU University
Projects
Project: Identification of new fungal Glycosylphosphatidylinositol (GPI)-anchored wall transfer protein 1 (GWT1) inhibitors.
Goal:
Current Stage: Ongoing
Starting Date: 11/11/2024
Sponsored by: Medical Mycology Centre, University of Exeter, Medical Research Council, UK
Projects

Conference Details


User has not updated his/her Conferences.

Contributions


There are no views with that ID